Price $23.81 |
Market Cap
230.3M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
9.61
|
P/S
6.0
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-4.2K
|
FCF
-0.5
|
|
Op. Margin
-18.10%
|
Net Margin
-18.10%
|
ROE
-28.30%
|
ROI
-27.10%
|
|
ROA
-23.10%
|
EPS Growth
10.20%
|
Current Ratio
5.2
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Invo Bioscience Inc (IVOB) | $0.36 | - | - | 62.2M | Strong Buy |
| Natus Medical Inc (BABY) | $25.87 | - | - | 838.9M | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $1.87 | - | - | 72.7M | Strong Buy |
| Allergan plc (AGN) | $166.08 | - | 1.80% | 53.76B | Strong Buy |
| Allied Healthcare Products Inc (AHPI) | $1.84 | - | - | 7.2M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
